These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6306671

  • 1. Arginine8 vasopressin potentiates the beta-endorphin-releasing activity of ovine corticotropin-releasing factor (oCRF) in vitro.
    Culler MD, Turkelson CM, Thomas CR, Arimura A.
    Proc Soc Exp Biol Med; 1983 Jun; 173(2):264-9. PubMed ID: 6306671
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
    Knepel W, Homolka L, Vlaskovska M, Nutto D.
    Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
    [Abstract] [Full Text] [Related]

  • 3. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M, Hertting G, Knepel W.
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical studies with synthetic ovine corticotropin-releasing factor.
    Orth DN, DeBold CR, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Uderman H, Alexander AN, Island DP, Rivier J.
    Fed Proc; 1985 Jan; 44(1 Pt 2):197-202. PubMed ID: 2981741
    [Abstract] [Full Text] [Related]

  • 8. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA, Holmes MC, Makara GB, Kárteszi M, László FA.
    Peptides; 1984 Jan; 5(3):519-22. PubMed ID: 6089144
    [Abstract] [Full Text] [Related]

  • 9. In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin.
    Turkelson CM, Thomas CR, Arimura A, Chang D, Chang JK, Shimizu M.
    Peptides; 1982 Jan; 3(2):111-3. PubMed ID: 6285317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in releasability of ACTH and beta-endorphin with chronic stress.
    Young E, Akil H.
    Neuropeptides; 1985 Feb; 5(4-6):545-8. PubMed ID: 2987742
    [Abstract] [Full Text] [Related]

  • 14. Pituitary receptors for corticotropin-releasing factor: no effect of vasopressin on binding or activation of adenylate cyclase.
    Holmes MC, Antoni FA, Szentendrei T.
    Neuroendocrinology; 1984 Aug; 39(2):162-9. PubMed ID: 6089019
    [Abstract] [Full Text] [Related]

  • 15. Release of prostaglandin E2 and beta-endorphin-like immunoreactivity from rat adenohypophysis in vitro: variations after adrenalectomy or lesions of the paraventricular nuclei.
    Knepel W, Vlaskovska M, Meyer DK.
    Brain Res; 1985 Feb 04; 326(1):87-94. PubMed ID: 3155985
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphin release: effects of acute and chronic stress.
    Young EA, Akil H.
    Endocrinology; 1985 Jul 04; 117(1):23-30. PubMed ID: 2988916
    [Abstract] [Full Text] [Related]

  • 17. The effect of various corticotropin-releasing factor trains on the release of adrenocorticotropin, beta-endorphin, and beta-lipotropin from perifused ovine pituitary cells.
    Evans MJ, Brett JT, McIntosh RP, McIntosh JE, Roud HK, Livesey JH, Donald RA.
    Endocrinology; 1985 Sep 04; 117(3):893-9. PubMed ID: 2990876
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.
    Spinedi E, Negro-Vilar A.
    Neuroendocrinology; 1983 Dec 04; 37(6):446-53. PubMed ID: 6318148
    [Abstract] [Full Text] [Related]

  • 19. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
    Chan JS, Gaspar L, Iguchi H, Seidah NG, Ling N, Chrétien M.
    Clin Invest Med; 1984 Dec 04; 7(4):205-8. PubMed ID: 6335868
    [Abstract] [Full Text] [Related]

  • 20. Interaction of synthetic ovine corticotropin releasing factor and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats.
    Murakami K, Hashimoto K, Ota Z.
    Neuroendocrinology; 1984 Jul 04; 39(1):49-53. PubMed ID: 6087183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.